167 related articles for article (PubMed ID: 12629996)
1. Decreased production of anti-mouse antibody after administration of human/mouse chimeric monoclonal antibody-neocarzinostatin conjugate to human.
Yata Y; Otsuji E; Okamoto K; Tsuruta H; Kobayashi S; Toma A; Yamagishi H
Hepatogastroenterology; 2003; 50(49):80-4. PubMed ID: 12629996
[TBL] [Abstract][Full Text] [Related]
2. Effects of idiotypic human anti-mouse antibody against in vitro binding and antitumor activity of a monoclonal antibody-drug conjugate.
Otsuji E; Tsuruta H; Toma A; Kobayashi S; Okamoto K; Yata Y; Yamagishi H
Hepatogastroenterology; 2003; 50(50):380-4. PubMed ID: 12749227
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effect of neocarzinostatin conjugated to human/mouse chimeric Fab fragments of the monoclonal antibody A7 on human pancreatic carcinoma.
Otsuji E; Yamaguchi T; Yata Y; Nishi H; Okamoto K; Taniguchi K; Kato M; Kotani T; Yamaoka N; Kitamura K
J Surg Oncol; 1994 Dec; 57(4):230-4. PubMed ID: 7990477
[TBL] [Abstract][Full Text] [Related]
4. Decreased renal accumulation of biotinylated chimeric monoclonal antibody-neocarzinostatin conjugate after administration of avidin.
Otsuji E; Yamaguchi T; Yamamoto K; Matsumura H; Tsuruta H; Yata Y; Nishi H; Okamoto K; Kitamura K; Takahashi T
Jpn J Cancer Res; 1997 Feb; 88(2):205-12. PubMed ID: 9119750
[TBL] [Abstract][Full Text] [Related]
5. [Immunoresponses and efficacy after arterial infusion of immunoconjugate A7-NCS in patients with colon cancer].
Honda M; Yamaguchi T; Ohtsuji E; Noguchi A; Chimori Y; Doi M; Kamiguchi M; Noguchi A; Kitamura K; Yokota T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1811-4. PubMed ID: 2143891
[TBL] [Abstract][Full Text] [Related]
6. [Missile therapy of colorectal and pancreatic cancers--clinical trial of monoclonal antibody, A7-NCS, in 73 patients with colorectal and pancreatic cancers].
Takahashi T; Yamaguchi T; Kitamura K; Noguchi A; Honda M; Otsuji E
Gan To Kagaku Ryoho; 1990 Jun; 17(6):1111-9. PubMed ID: 2140933
[TBL] [Abstract][Full Text] [Related]
7. Distribution of neocarzinostatin conjugated to biotinylated chimeric monoclonal antibody Fab fragments after administration of avidin.
Otsuji E; Yamaguchi T; Matsumura H; Yamamoto K; Tsuruta H; Yata Y; Nishi H; Okamoto K; Kitamura K; Takahashi T
Br J Cancer; 1996 Aug; 74(4):597-602. PubMed ID: 8761376
[TBL] [Abstract][Full Text] [Related]
8. Effects of neocarzinostatin-chimeric Fab conjugates on the growth of human pancreatic carcinoma xenografts.
Otsuji E; Yamaguchi T; Tsuruta H; Yata Y; Nishi H; Okamoto K; Taniguchi K; Kato M; Kotani T; Kitamura K; Takahashi T
Br J Cancer; 1996 May; 73(10):1178-82. PubMed ID: 8630275
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution of neocarzinostatin conjugated to chimeric Fab fragments of the monoclonal antibody A7 in nude mice bearing human pancreatic cancer xenografts.
Otsuji E; Yamaguchi T; Yamaoka N; Taniguchi K; Kato M; Kotani T; Kitamura K; Takahashi T
Jpn J Cancer Res; 1994 May; 85(5):530-5. PubMed ID: 8014111
[TBL] [Abstract][Full Text] [Related]
10. Applicability of monoclonal antibody Fab fragments as a carrier of neocarzinostatin in targeting chemotherapy.
Otsuji E; Yamaguchi T; Tsuruta H; Yata Y; Nishi H; Okamoto K; Taniguchi K; Kato M; Kotani T; Kitamura K; Takahashi T
J Surg Oncol; 1996 Feb; 61(2):149-54. PubMed ID: 8606548
[TBL] [Abstract][Full Text] [Related]
11. [Missile therapy using monoclonal antibody drug conjugates in colorectal carcinoma].
Takahashi T; Yamaguchi T; Yokota T; Kitamura K; Suzuyama H; Honda M; Otsuji E; Sawai K; Sakita M; Kotanagi H
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):931-7. PubMed ID: 2952068
[TBL] [Abstract][Full Text] [Related]
12. In vivo efficacy of neocarzinostatin coupled with Fab human/mouse chimeric monoclonal antibody A7 against human colorectal cancer.
Yamaguchi T; Tsurumi H; Kotani T; Yamaoka N; Otsuji E; Kitamura K; Takahashi T
Jpn J Cancer Res; 1994 Feb; 85(2):167-71. PubMed ID: 8144398
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of intra-peritoneal and intra-venous injection of monoclonal antibody A7-NCS conjugates against peritoneal dissemination of the gastric cancer].
Kuriu Y; Otsuji E; Okamoto K; Ichikawa D; Fujiwara H; Ochiai T; Sakakura C; Ueda Y; Sonoyama T; Hagiwara A; Yamagishi H
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1842-3. PubMed ID: 15553733
[TBL] [Abstract][Full Text] [Related]
14. [Clinical application of monoclonal antibody-drug conjugates in colorectal carcinoma].
Takahashi T; Sakita M; Yamaguchi T; Kitamura K; Hata K; Noguchi A
Gan To Kagaku Ryoho; 1988 May; 15(5):1702-9. PubMed ID: 2967049
[TBL] [Abstract][Full Text] [Related]
15. Local administration of monoclonal antibody-drug conjugate: a new strategy to reduce the local recurrence of colorectal cancer.
Kitamura K; Takahashi T; Kotani T; Miyagaki T; Yamaoka N; Tsurumi H; Noguchi A; Yamaguchi T
Cancer Res; 1992 Nov; 52(22):6323-8. PubMed ID: 1423277
[TBL] [Abstract][Full Text] [Related]
16. [Effect of monoclonal antibody-neocarzinostatin conjugate for gastric cancer with peritoneal dissemination--comparison between early and late administration].
Okamoto K; Otsuji E; Toma A; Kobayashi S; Kitamura K; Yamaguchi T; Yamagishi H
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1508-10. PubMed ID: 11707966
[TBL] [Abstract][Full Text] [Related]
17. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.
Gruber R; van Haarlem LJ; Warnaar SO; Holz E; Riethmüller G
Cancer Res; 2000 Apr; 60(7):1921-6. PubMed ID: 10766181
[TBL] [Abstract][Full Text] [Related]
18. Absence of anti-neocarzinostatin (NCS) antibody production in leukemia patients treated with NCS.
Toki H
Acta Med Okayama; 1976 Apr; 30(2):135-42. PubMed ID: 135485
[TBL] [Abstract][Full Text] [Related]
19. Application of 99mTc labeled chimeric Fab fragments of monoclonal antibody A7 for immunoscintigraphy of pancreatic carcinoma.
Otsuji E; Matsumura H; Okamoto K; Toma A; Kuriu Y; Ichikawa D; Hagiwara A; Yamagishi H
J Surg Oncol; 2003 Nov; 84(3):160-5. PubMed ID: 14598360
[TBL] [Abstract][Full Text] [Related]
20. [Host factors that changes the distribution of immunotoxin].
Yamaguchi T; Takahashi T; Yokota T; Kitamura K; Noguchi A; Doi M; Chimori Y; Honda M; Noguchi A; Otsuji E
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):570-4. PubMed ID: 2138873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
